Q1 2018 Holdings
Filed 2018-05-15 | 34 holdings | $224.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | ADR | 04351P101 | $141.7M | 2,166,832 | 63.1% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $33.6M | 3,054,825 | 15.0% |
| Aclaris Therapeutics(ACRS) | Common | 00461U105 | $28.9M | 1,647,214 | 12.8% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $13.7M | 1,900,000 | 6.1% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $6.3M | 1,213,290 | 2.8% |
| Menlo Therapeutics | Common | 586858102 | $150.7K | 4,011,236 | 0.1% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | Common | G11196105 | $52.8K | 2,049,545 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | Common | 03753U106 | $32.2K | 1,457,834 | 0.0% |
| Verona Pharma Plc(VRNA) | ADS | 925050106 | $29.9K | 1,492,951 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $21.7K | 1,159,742 | 0.0% |
| Nabriva Therapeutics Plc | SHS | G63637105 | $20.5K | 4,074,190 | 0.0% |
| Amyris, Inc.(AMRSEUR) | Common | 03236M200 | $18.9K | 2,826,711 | 0.0% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $17.6K | 1,791,257 | 0.0% |
| Strongbridge Biopharma plc | SHS USD | G85347105 | $17.0K | 1,918,132 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $16.5K | 1,043,020 | 0.0% |
| Kadmon Holdings (Kdmn)(KDMN) | Common | 48283N106 | $14.2K | 3,333,333 | 0.0% |
| Selecta Biosciences, Inc.(SELBUSD) | Common | 816212104 | $11.4K | 1,119,189 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $10.4K | 800,000 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | Common | 00900T107 | $9.8K | 306,872 | 0.0% |
| Genocea Biosciences Inc | Common | 372427104 | $8.6K | 8,180,000 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203200 | $7.3K | 4,033,534 | 0.0% |
| Zai Lab LTD(ZLAB) | ADR | 98887Q104 | $6.1K | 283,787 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $5.0K | 2,438,270 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $4.9K | 164,403 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $4.4K | 855,000 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $4.2K | 105,000 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $3.9K | 1,513,975 | 0.0% |
| BioPharmX Corporation | Common | 09072X101 | $3.7K | 16,128,515 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $3.2K | 27,220 | 0.0% |
| KalVista Pharmaceuticals, Inc.(KALV) | Common | 483497103 | $2.8K | 300,325 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $2.8K | 1,728,000 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $629 | 345,850 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | Common Par | 867328700 | $532 | 195,474 | 0.0% |
| Soleno Therapeutics, Inc. | Warrant | 834203135 | $23 | 188,772 | 0.0% |